Virios Therapeutics (VIRI) Reports Q4 Loss of $1.25/sh

Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($1.25), versus ($0.13) reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform